Results 61 to 70 of about 180 (132)

EFFECT OF COMBINATION THERAPY WITHFOSINOPRIL AND MELDONIUM ON THE INDICES OF 48-HOUR MONITORING OF BLOOD PRESSURE AND MYOCARDIUM GEOMETRY IN HEMODIALYSIS PATIENTS WITH CHRONIC HEART FAILURE

Український Журнал Нефрології та Діалізу, 2017
Despite medical advances, cardiovascular complications continue to dominate in patients treated with hemodialysis. Therefore, the search for new methods of diagnosis and treatment is advisable.
T.I. Salyzhyn
doaj   +1 more source

A comparative study of pharmacokinetics and bioequivalence of Cardiopril tablets 20 mg (JSC «Himfarm», Kazakhstan) and Monopril® tablets of 20 mg («Bristol-Myers Squibb SRL», Italy)

Фармакокинетика и Фармакодинамика, 2014
In a single-dose, two-treatment, two-period, two-sequence crossover study with a 1-week washout period was carry out the bioequivalence study of two tablet coated formulation of fosinopril that given to 18 volunteers in equal doses (20 mg).
A. K. Sariev, D. A. Abaimov, M. V. Tankevich, S. A. Altinbekov, G. A. Dzholdygulov, V. N. Seryakov, Y. . Budach, O. . Kurilov   +7 more
doaj  

CONDITION OF LIPID PEROXIDATION IN HYPERTENSIVES WITH A YEAR-LONG TREATMENT WITH MIFEBRADIL, FOSINOPRIL AND DOXASOSINE

Российский кардиологический журнал, 2000
Condition of lipid peroxidation in hypertensives with a year-long treatment with mifebradil, fosinopril and doxasosine.
V. A. Orlov, A. I. Trankin, S. I. Afonin
doaj  

Fozinopril in the treatment of cardiorenal syndrome in chronic cardiac failure

Терапевтический архив, 2009
Renal dysfunction is an independent risk factor of chronic cardiac failure (CCF) and death due to this disease. CCF patients are elderly patients with diabetes mellitus, arterial hypertension and long-term chronic cardiac insufficiency.
S N Tereshchenko, I V Zhirov, S N Tereschenko, I V Zhirov   +3 more
doaj  

Fosinopril

Revista de Medicina de la Universidad de Navarra, 2016
E.G. Quetglas, M. Simón, J. Honorato
openaire   +2 more sources

Conceptual approaches to cerebral blood flow correction in postmenopausal women with arterial hypertension

Кардиоваскулярная терапия и профилактика, 2005
Aim. To assess cerebral blood flow and cholesterol (CH) metabolism in postmenopausal women with arterial hypertension (AH); to evaluate dynamics of cerebral blood flow and lipid profile during 6-month antihypertensive and hypolipidemic therapy.
V. V. Yakusevich, M. E. Mozeyko, N. V. Sudareva   +2 more
doaj  

Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway

Open Life Sciences
Fosinopril (FOS) is an angiotensin-converting enzyme inhibitor that can decrease angiotensin II (Ang II) formation, thereby reducing systemic vasoconstriction.
Chen Siqi, Ye Lingxiang
doaj   +1 more source

Clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension and coronary heart disease

Кардиоваскулярная терапия и профилактика, 2008
Aim. To compare clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension (AH) and coronary heart disease (CHD), aiming to guide the appropriate medication selection process.Material and methods.
O. Yu. Korennova, A. V. Petrenko, M. A. Petrenko, E. V. Kurt-Kovalenko, E. A. Turusheva, T. A. Natsarenus, S. V. Alekseeva, L. G. Mashinskaya, M. I. Shupina, E. A. Osipova   +9 more
doaj  

Fosinopril [PDF]

, 2020
openaire   +1 more source

Fosinopril Sodium [PDF]

, 2020
openaire   +1 more source